CRRT: Current effective delivered dose monitoring for continuous renal replacement therapy
The problem
“dose”: the amount of blood cleared of waste products and toxins by an extracorporeal device per unit of time.
In clinical practice there is a DYNAMIC and UNPREDICTABLE filter degradation: clottering and concentration polarization will contribute to the impairment of filter function
delivered dose is LOWER than prescribed dose BY 20-30%
dose under-treatment
higer mortality rate
The solution: A system for the automatic and frequent monitoring of delivered dose in CRRT treatments
In collaboration with:
PATENT PENDING EVALUATION: “Current effective delivered dose monitoring for continuous renal replacement therapy” (Original title: “Metodo per acquisire campioni biologici liquidi da un circuito extracorporeo per un trattamento di purificazione ematica extracorporea e relativi apparato e sistema”), Italian Patent Application N. IT102021000032621 of 24th December 2021, Inventors: V Cauda, A. Ancona, G. Villa, S. Romagnoli, Z. Ricci
This project has received funding from the LiFTT – LINKS POC INSTRUMENT 2021